Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with the site header, replacing the usual study record content with a notice.
    Difference
    18%
    Check dated 2026-09-20T03:15:15.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, representing a small update to the study page.
    Difference
    0.1%
    Check dated 2026-08-29T23:35:44.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.5 in place of the previous v3.6.4, indicating a minor update to the study record metadata. This change does not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T17:43:32.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a backend update. No study information or layout changes are introduced.
    Difference
    0.1%
    Check dated 2026-07-25T08:29:56.000Z thumbnail image
  7. Check
    97 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.2 to v3.6.3, indicating a newer revision of the page. This is a minor update applied to the page's underlying revision tag.
    Difference
    0.1%
    Check dated 2026-07-03T22:13:54.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.2 to indicate a newer page revision. This change is metadata and does not modify the study content or its presentation.
    Difference
    0.1%
    Check dated 2026-06-26T23:55:40.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.